CapsoVision

Historical price data

CapsoVision is focused on revolutionizing gastrointestinal diagnostics through its innovative capsule endoscopy technology. The company's core innovation is the CapsoCam Plus, a single-use capsule with four laterally oriented cameras that capture a full 360° panoramic view, aiming to increase diagnostic yield for conditions like obscure GI bleeding and Crohn's disease. Operating as a commercial-stage entity with FDA-cleared products, CapsoVision provides a complete system that includes the capsule, cloud-based software (CapsoCloud), and a retrieval kit, all designed to streamline clinical workflow and improve patient comfort. The company's mission is to empower clinicians and patients through imaging innovations that improve diagnostic outcomes and quality of life.

A wire-free capsule endoscopy platform featuring a single-use capsule with four laterally oriented cameras for 360° panoramic imaging of the GI tract, coupled with cloud-based software for remote data access and review.

Total raised: $70M

CapsoVision competes primarily with Medtronic's PillCam and Olympus's EndoCapsule, which use traditional axial-viewing technology. Its main differentiators are its 360° panoramic imaging, which aims to reduce missed diagnoses, and its completely wire-free, cloud-based system that improves patient comfort and offers clinics a zero-capex, scalable model.